sinman0531
Guru
We have had a recent influx of denials for inappropriate billing for this exact scenario:
-Provider takes shave biopsy and pathology comes back as malignant (specifically SCC).
-Provider schedules follow-up excision to confirm clean margins.
-Claim for follow up excision is denied as inappropriate because we are billing malignant codes, even though the pathology is coming back as no residual malignancy/clean margins.
All of the articles in coding magazines and blogs I have found confirm that if the excision is to confirm clean margins, then we are supposed to bill the malignant codes, even if the path comes back clean. However, for the life of me I cannot find an NCCI guideline or CMS guideline that says that. Does anyone have any idea where I can find one?
-Provider takes shave biopsy and pathology comes back as malignant (specifically SCC).
-Provider schedules follow-up excision to confirm clean margins.
-Claim for follow up excision is denied as inappropriate because we are billing malignant codes, even though the pathology is coming back as no residual malignancy/clean margins.
All of the articles in coding magazines and blogs I have found confirm that if the excision is to confirm clean margins, then we are supposed to bill the malignant codes, even if the path comes back clean. However, for the life of me I cannot find an NCCI guideline or CMS guideline that says that. Does anyone have any idea where I can find one?